Singular Genomics Regains Compliance with Nasdaq Minimum Bid Price Requirement
July 15, 2024 16:05 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, July 15, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to...
Singular Genomics Announces 1-for-30 Reverse Stock Split
June 21, 2024 16:05 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, June 21, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to...
Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference
May 29, 2024 16:05 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower...
Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results
May 14, 2024 16:05 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower...
Singular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024
May 01, 2024 16:05 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower...
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results
March 18, 2024 16:05 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, March 18, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to...
Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024
March 04, 2024 16:05 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, March 04, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...
Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform
February 05, 2024 10:55 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to...
Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis
February 05, 2024 10:54 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to...
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue
January 07, 2024 17:00 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, Jan. 07, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...